Article Sidebar
Published:
Apr 14, 2024Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Prevention of stress related mucosal damage using intravenous omeprazole
Abstract
Purpose: To evaluate the effect of using intravenous injection of omeprazole to prevent stress-related mucosal damage (SRMD) in critically ill patients.
Methods: 80 critically ill patients from the Eighth People's Hospital of Qingdao, Qingdao, China were recruited and randomly divided into control and study groups comprising 40 patients each. Control group received conventional symptomatic treatment comprising nutritional support, acid-base balance regulation, electrolyte level monitoring and correction, maintenance of fluid and electrolyte equilibrium, respiratory function management, and anti-infection measures. Study group received intravenous injection of omeprazole (20 mg/day) and conventional symptomatic treatment for 3 months. Treatment effect, gastric pH, and gastroscopic observation of the two groups of patients were recorded.
Results: The study group demonstrated significantly higher treatment efficacy (97.5 %) compared to control group (80 %, p < 0.05). Pre-treatment gastric pH did not differ significantly between the groups (p > 0.05). After treatment, the study group exhibited significantly higher pH levels (p < 0.05). Normal endoscopic findings increased to 85 % in the study group compared to 20 % in control group (p < 0.05).
Conclusion: Intravenous omeprazole significantly prevents SRMD in critically ill patients, improves gastric pH regulation and reduces abnormal endoscopic findings. Larger-scale, multicenter, and long-term studies are needed to validate the findings of this study.
